Multiple Sclerosis study: MRI Contrast
Official title Central Vein Sign in Multiple Sclerosis Extension Study
ClinicalTrials.gov ID: NCT07424027
What this study is testing
- What it's testing
- The study wants to learn whether these MRI markers can improve diagnosis and help monitor disease changes in people with MS.
- Who it's for
- It is looking for 40 people who have been diagnosed with multiple sclerosis.
- What's involved
- Participants will have high‑resolution brain MRIs, some with contrast, at several visits to look for the markers and track how lesions change.
- Time commitment
- The study lasts 48 months, with multiple MRI visits spread over that time.
- Time commitment: about 48 months
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Participants must be enrolled in and meet all of the CAVS-MS study.
- Must have participated in the CAVS-MS study and have completed month 24 visits.
- Able to provide written informed consent to participate in the study.
You likely can't join if
- Contraindication to MRI studies; metal or metal implants incompatible with MRI
- Inability to tolerate MRI due to claustrophobia or known excessive movement (e.g. tremor).
The study team makes the final eligibility decision.
Where it is enrolling
- Cleveland, Ohio, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The study runs about 48 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Cleveland, Ohio, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.